Search our Database of Scientific Publications and Authors

I’m looking for a

    7983 results match your criteria Catheterization and Cardiovascular Interventions[Journal]

    1 OF 160

    Frailty in nonagenarians: A bridge too far?
    Catheter Cardiovasc Interv 2017 Nov;90(6):1007-1008
    Lankenau Heart Institute.
    There is no clear consensus about the definition of frailty and how to accurately measure it. There is accumulating evidence that frail old patients have worse outcomes after TAVR compared to non-frail patients. Further randomized research is needed to confirm those concerns and to standardize the role of frailty assessment in patient selection for TAVR. Read More

    Recurrent coarctation of aorta after Norwood operation in single ventricle patients; the case of the missing ideal stent.
    Catheter Cardiovasc Interv 2017 Nov;90(6):980-981
    Department of Cardiology, Texas Heart Institute, 6624 Fannin, Suite 2780, Houston, TX.
    Recurrent coarctation postoperative Norwood is poorly tolerated in single ventricle patients. Although transcatheter balloon angioplasty is considered first line, it often leads to inadequate or non-durable relief of obstruction. Transcatheter stent implantation provides excellent relief of obstruction but necessitates staged redilation to account for somatic growth in children. Read More

    Does the severity of left ventricular systolic dysfunction impact outcomes of Mitraclip therapy: How low is too low?
    Catheter Cardiovasc Interv 2017 Nov;90(6):1046-1047
    Robertwood Johnson Medical School, New Brunswick, NJ.
    Percutaneous mitral valve repair for symptomatic severe mitral regurgitation has rapidly evolved as a viable therapeutic option for high-surgical risk patients. Both randomized clinical studies as well as real world registry data have demonstrated significant improvement in severity of MR and clinical outcomes. In carefully selected patients with severely reduced left ventricular systolic function and severe symptomatic MR, Mitraclip therapy seems to show promise. Read More

    Real life experience with bioresorbable-polymer everolimus-eluting stents. Is this an answer in search of a question?
    Catheter Cardiovasc Interv 2017 Nov;90(6):888-889
    Cardiac Catheterization Laboratory and Division of Cardiology, Tufts Medical Center, Boston, Massachusetts.
    Stent thrombosis and clinically driven restenosis are rare in the era of newer generation DES. The Synergy bioresorbable polymer DES appears to be comparable to other durable polymer and other bioabsorbable polymer DES in terms of safety and efficacy at 1-year post implantation. Further long-term study is needed to determine the specific role of the Synergy stent and other DES with bioabsorbable polymers. Read More

    Are new devices required to reduce contrast load in the cath lab, or is behavioral change sufficient?
    Catheter Cardiovasc Interv 2017 Nov;90(6):935-936
    MedStar Washington Hospital Center, Washington, District of Columbia.
    A novel device that diverts a proportion of contrast injected by hand through the manifold can potentially reduce volume of contrast delivered to the patient by almost 50% to reduce risk of contrast-induced nephropathy. Another simple solution to reducing contrast volume is to limit the number of angiographic views and cine runs acquired. A conscious effort by the angiographer to limit the contrast volume to less than the eGFR should be considered. Read More

    Infrapopliteal peripheral arterial disease and critical limb ischemia: The time has come for collaborative, streamlined diagnostic, and treatment paradigms.
    Catheter Cardiovasc Interv 2017 Nov;90(6):994-995
    Sections of Vascular Medicine and Interventional Cardiology, Department of Cardiology, Lahey Hospital and Medical Center, Tufts University School of Medicine, Burlington, Massachusetts.
    The diagnosis, surveillance, and management of infrapopliteal critical limb ischemia remain inconsistent among clinicians. This study demonstrates that using an absolute ankle pressure of >73 mm Hg or an absolute toe pressure increase of 1 mm Hg or greater post endovascular intervention in patients with infrapopliteal critical limb ischemia may be predictive of a reduction in target limb revascularization, amputation, and death. This study highlights the need for vascular societies to come together to promote standardized screening, surveillance, and treatment paradigms for this complex population. Read More

    Peri-procedural myocardial infarction: Plaques and patients "at-risk".
    Catheter Cardiovasc Interv 2017 Nov;90(6):915-916
    Department of Cardiovascular Medicine, Beaumont Health System, Royal Oak, Michigan.
    Patients with acute coronary syndrome are at risk for peri-procedural myocardial infarction (PMI) Lipid-laden plaques with thinned disrupted fibrous caps are most prone to PMI PMI is associated with worse outcome over time, though whether such damaging events are causal or instead reflect patients prone to future instability from non-culprit vulnerable plaques requires further delineation. Read More

    What can intracoronary pressure measurements tell us about CFR? Now comes pb-CFR.
    Catheter Cardiovasc Interv 2017 Nov;90(6):926-927
    Division of Cardiology, Department of Medicine, Regional Heart Center, University of Washington, Seattle, Washington.
    Pressure-bound (pb) coronary flow reserve (CFR) is a novel estimation of CFR, calculated from easily obtained baseline and hyperemic pressure assessment Validation of pb-CFR in previously reported lesions showed accuracy of 84% to CFR with sensitivity of 96% and specificity of 60% FFR >0.75 and low pb-CFR in DEFER was associated with increased angina and complications compared to high pb-CFR and this risk was not modified by elective revascularization. Read More

    Utility of the ACC/AHA lesion classification as a predictor of procedural, 30-day and 12-month outcomes in the contemporary percutaneous coronary intervention era.
    Catheter Cardiovasc Interv 2017 Nov 15. Epub 2017 Nov 15.
    Department of Cardiology, Austin Health, Melbourne.
    Background: Correlations between the ACC/AHA coronary lesion classification and clinical outcomes in the contemporary percutaneous coronary intervention (PCI) era are not well established.

    Methods: We analyzed clinical characteristics and outcomes according to ACC/AHA lesion classification (A, B1, B2, C) in 13,701 consecutive patients from the Melbourne Interventional Group (MIG) registry. Patients presenting with STEMI, cardiogenic shock and out-of-hospital cardiac arrest were excluded. Read More

    Role of vascular ultrasound scanning in repeated trans-radial coronary artery intervention (prospective randomized study).
    Catheter Cardiovasc Interv 2017 Nov 13. Epub 2017 Nov 13.
    Cardiology Department, Aswan Heart Centre, Aswan, Egypt.
    Objectives: We aimed to detect if pre-procedure vascular ultrasound scanning (VUS) of radial arteries (RAs) can increase the radial access success (RAS) rate and/or reduce the vascular access time (VAT), by guiding the choice of the proper access site for repeated trans-radial interventions (TRIs).

    Background: Currently, repeated-TRIs are encountered more frequently in most of the cath. labs. Read More

    Balloon pin-hole rupture during percutaneous coronary intervention for recurrent, calcified in-stent restenosis: A case report.
    Catheter Cardiovasc Interv 2017 Nov 13. Epub 2017 Nov 13.
    Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
    Percutaneous coronary intervention (PCI) for patients with in-stent restenosis (ISR) is generally considered safe and effective. However, due to increased tissue hardness, PCI for calcified intra-stent ISR is technically challenging. Here, we report severe angioplasty-related complications in a patient presenting with calcified, recurrent ISR following PCI. Read More

    Emergent percutaneous therapy for left ventricular assist device retrograde flow.
    Catheter Cardiovasc Interv 2017 Nov 11. Epub 2017 Nov 11.
    Division of Cardiothoracic Surgery, University of Kentucky, 900 South Limestone, Room 326 Wethington Building, Lexington, Kentucky, 40536.
    With the number of heart transplants being performed each year stagnating due to lack of donors the left ventricular assist device (LVAD) patient population will continue to grow. As more and more patients are living longer with LVADs, either as a bridge to transplant or destination therapy, we will continue to see an increased number of complications related to assist device therapy. One of the common challenges physicians face are patients who suffer from both bleeding and thrombotic complications. Read More

    Thromboembolism after WATCHMAN(TM) in a clopidogrel non-responder: A case for concern?
    Catheter Cardiovasc Interv 2017 Nov 11. Epub 2017 Nov 11.
    Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church, Virginia.
    Atrial fibrillation (AF) is associated with an increased risk of stroke and thromboembolism (TE). The WATCHMAN(TM) left atrial appendage (LAA) closure device is indicated to reduce the risk of TE from the LAA in patients with non-valvular AF. Here, we present a case of a patient with device-related thrombus who suffered a TE event two months after WATCHMAN(TM) LAA closure and two weeks after switching from aspirin plus warfarin to aspirin plus clopidogrel therapy. Read More

    A feasibility study of transaxillary TAVI with the lotus valve.
    Catheter Cardiovasc Interv 2017 Nov 11. Epub 2017 Nov 11.
    Queen Elizabeth Hospital, Birmingham, United Kingdom.
    Objectives: To assess the feasibility of axillary transcatheter aortic valve implantation (TAVI) using the Lotus valve.

    Background: TAVI is used to treat patients with severe aortic stenosis, with transfemoral (TF) access being the safest and most widely used route. In patients unsuitable for this, there are reports that the axillary artery may be safest alternative access route. Read More

    Emergency extracorporeal membrane oxygenation in transcatheter aortic valve implantation: A two-center experience of incidence, outcome and temporal trends from 2010 to 2015.
    Catheter Cardiovasc Interv 2017 Nov 11. Epub 2017 Nov 11.
    Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technical University Munich, Munich, Germany.
    Background: Although the incidence of periprocedural complications has decreased in transcatheter aortic valve implantation (TAVI), life-threatening complications occur and emergency veno-arterial extracorporeal membrane oxygenation (vaECMO) can provide immediate circulatory stabilization. We report our two-center experience of vaECMO during life-threatening complications in TAVI.

    Methods: From January 2010 to December 2015, 1,810 consecutive patients underwent TAVI at two centers. Read More

    Impact of anemia on long-term outcomes after percutaneous coronary intervention for chronic total occlusion.
    Catheter Cardiovasc Interv 2017 Nov 11. Epub 2017 Nov 11.
    Division of Cardiology and Angiology II, University Heart Center Freiburg - Bad Krozingen, Germany.
    Objectives: A single-centre, observational study was performed in order to investigate the relationship between anemia and outcomes after percutaneous coronary intervention (PCI) for chronic total occlusion (CTO).

    Background: Anemia has been identified as adverse predictor in patients with coronary artery disease undergoing coronary revascularization. Data on the impact of anemia on outcomes in patients undergoing PCI for CTO lesions are lacking. Read More

    Caliber and fitness of the axillary artery as a conduit for large-bore cardiovascular procedures.
    Catheter Cardiovasc Interv 2017 Nov 11. Epub 2017 Nov 11.
    Department of Medicine, Division of Cardiology, University of Washington, Seattle, Washington.
    Objectives: We sought to describe the caliber and vascular health of the subclavian and axillary arteries as related to their potential utilization in complex cardiovascular procedures.

    Background: Patients referred for advanced catheter-based therapies frequently have lower extremity peripheral vascular disease that may prohibit the use of large bore arterial catheters. Utilization of the upper extremity peripheral vasculature is rarely considered as an alternative access strategy. Read More

    Pushing boundaries: Implantation of the 34 mm Medtronic CoreValve in patients with a large aortic annulus.
    Catheter Cardiovasc Interv 2017 Nov 11. Epub 2017 Nov 11.
    Department of Cardiothoracic Surgery, New York Presbyterian Hospital-Weill Cornell Medicine, New York, New York.
    The relationship between adherence to the recommended CoreValve sizing parameters and clinical outcomes is not well known for the recently released 34 mm valve, which is currently the largest available transcatheter valve. There is a presumed temporal reduction in paravalvular regurgitation in patients who receive an in-range valve, however, certain patients possess annular dimensions that are too large. We therefore describe two patients with annular dimensions larger than the manufacturer recommended range for the 34 mm CoreValve, who despite this underwent transcatheter aortic valve replacement with excellent clinical outcomes. Read More

    Periprocedural transfusion in patients undergoing transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv 2017 Nov 11. Epub 2017 Nov 11.
    Institut für Anästhesiologie, Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München, Lazarettstr. 36, Munich, D-80636, Germany.
    Objectives: The aim of this investigation was to identify patient's characteristics and periprocedural variables related to periprocedural transfusion in transfemoral Transcatheter Aortic Valve Implantation (tf-TAVI).

    Background: Transfusion of allogenic red-blood cells (RBC) in tf-TAVI and the number of transfused units has been linked to an increased 30-day mortality. In line with the trend of minimization and cost-effectiveness, transfusion should be avoided, wherever possible. Read More

    Planned angiographic control versus clinical follow-up for patients with unprotected left main stem stenosis treated with second generation drug-eluting stents: A propensity score with matching analysis from the FAILS (failure in left main with second generation stents-Cardiogroup III Study).
    Catheter Cardiovasc Interv 2017 Nov 11. Epub 2017 Nov 11.
    Dipartimento di Scienze Mediche, Divisione di Cardiologia, Città della Salute e della Scienza, Turin, Italy.
    Background: The value of angiographic follow-up in unprotected left main (ULM) stenting remains undefined.

    Methods: The FAILS-2 registry included consecutive patients presenting with a critical lesion of an ULM treated with second generation drug eluting stents in 6 centers from June 2007 to January 2015. Patients were stratified into two groups: those discharged with planned angiographic follow-up and those with clinical follow-up. Read More

    Transverse partial stent ablation with rotational atherectomy for suboptimal culotte technique in left main stem bifurcation.
    Catheter Cardiovasc Interv 2017 Nov 6. Epub 2017 Nov 6.
    Oxford Heart Centre, NIHR Biomedical Research Centre, Oxford University Hospitals, Oxford, United Kingdom.
    Longitudinal rotational atherectomy of metal struts is well described as bail-out strategy to treat undilatable instent restenosis. Ablation of metal stent struts jailing the ostium of a major side branch in a coronary bifurcation is not described. In the current report, we describe a case of "transverse" rotational atherectomy to treat a failure of culotte stenting in a left main stem bifurcation. Read More

    Hemodynamic classification of paravalvular leakage after transcatheter aortic valve implantation compared with angiographic or echocardiographic classification for prediction of 1-year mortality.
    Catheter Cardiovasc Interv 2017 Nov 6. Epub 2017 Nov 6.
    Department of Cardiology, Heart Center Bad Segeberg, Segeberger Kliniken, Germany.
    Objectives: We sought to assess angiographic, echocardiographic and hemodynamic grading of paravalvular leakage (PVL) after transcatheter aortic valve implantation (TAVI) with respect to prediction of 1-year mortality.

    Background: Meaningful criteria for the severity of PVL are needed to allow intraprocedural guidance and patient management after TAVI.

    Methods: We pooled the prospective TAVI databases of 2 German centers. Read More

    Simultaneous transcatheter transfemoral aortic and transeptal mitral valve replacement using Edward SAPIEN S3.
    Catheter Cardiovasc Interv 2017 Nov 6. Epub 2017 Nov 6.
    Division of Cardiology, Prairie Heart Institute, Springfield, Illinois.
    Patients with concomitant severe aortic stenosis (AS) and severe mitral stenosis (MS) with mitral annular calcification (MAC) constitute an elderly high-risk population with multiple baseline comorbidities that coexist even before they develop severe valvular dysfunction. Transcatheter mitral valve replacements (TMVR) offer an alternative option for high-risk patient with severe MS with MAC. A simultaneous transfemoral Transcatheter aortic valve replacement (TAVR) and transseptal TMVR is feasible and offers the least invasive approach of management. Read More

    Comparison of self-expanding and balloon-expandable transcatheter aortic valves morphology and association with paravalvular regurgitation: Evaluation using multidetector computed tomography.
    Catheter Cardiovasc Interv 2017 Nov 6. Epub 2017 Nov 6.
    Department of Cardiology, Gaia/Espinho Hospital Center, Rua Conceição Fernandes, Vila Nova de Gaia, 4434-502, Portugal.
    Objectives: Compare final morphology of self-expanding and balloon-expandable prosthesis and association with paravalvular regurgitation (PVR).

    Background: PVR after transcatheter aortic valve replacement (TAVR) remains a frequent complication. A better understanding of the prosthesis geometry may be important to improve selection of the best device for each case and possibly reduce the rates of PVR. Read More

    Anticoagulation with heparin The art of simplicity even in patients on dialysis.
    Catheter Cardiovasc Interv 2017 Nov;90(5):733-734
    Department of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
    In current PCI practice, anticoagulation with either bivalirudin or unfractionated heparin in patients with ACS share comparable efficacy and safety. Nonetheless, their individual performance in patients on dialysis remains unclear. This observational PCI study reported in-hospital clinical outcome in patients on dialysis undergoing PCI according to drug regimen: bivalirudin versus heparin. Read More

    PVL closure after TAVR: Yes, we can do it.
    Catheter Cardiovasc Interv 2017 Nov;90(5):878
    Arkansas Heart Hospital, Little Rock, AR.
    Paravalvular leak (PVL) remains a significant problem after transcatheter aortic valve replacement. PVL is associated with long-term morbidity and mortality. Percutaneous management of post-TAVR PVL seems to be feasible and should be adopted by the structural heart interventionalist. Read More

    If you prick us, do we not bleed?
    Catheter Cardiovasc Interv 2017 Nov;90(5):743-744
    Cedars-Sinai Heart Institute, Los Angeles, California.
    Women have higher post PCI bleeding complications which in turn contributes to higher post PCI mortality. Bivalirudin decreases bleeding events in both men and women when compared to use of both heparin and GPI but bleeding avoidance strategies such as radial artery access or avoiding GPI may modify that benefit. The NCDR bleeding risk score incorporates gender and is predictive of both bleeding complications and mortality. Read More

    Does the end justify the means? The contemporary role of dissection/re-entry strategies for recanalization of coronary chronic total occlusions.
    Catheter Cardiovasc Interv 2017 Nov;90(5):713-714
    Division of Interventional Cardiology, Minneapolis Heart Institute, Minneapolis, Minnesota.
    Antegrade and retrograde dissection/re-entry techniques are frequently utilized in contemporary CTO PCI, especially for complex lesions. One-year outcomes with modern dissection/re-entry techniques appear favorable and comparable with those achieved after intraplaque crossing, supporting their increased use. Randomized data on the procedural safety, efficiency, and long-term outcomes of subadventitial CTO PCI techniques are needed. Read More

    Hemodynamic guidance of mitral paravalvular leak closure: The V is the key.
    Catheter Cardiovasc Interv 2017 Nov;90(5):859-860
    Department of Cardiovascular Medicine, William Beaumont Hospital, Royal Oak, Michigan.
    Severe mitral paravalvular leak (PVL) induces elevated mean left atrial (LA) pressure (LAP) and prominent V waves, leading to pulmonary hypertension and right heart failure PVL closure promptly reduces V wave and mean LAP, correlates with improved echo regurgitation grade, and exerts immediate benefit to the lungs and right heart Hemodynamic response patterns facilitate PVL closure. Read More

    Coronary resting gradients for hemodynamic lesion assessment - The future of coronary physiology?
    Catheter Cardiovasc Interv 2017 Nov;90(5):754-755
    Department of Cardiology, St. Francis Hospital, Roslyn, New York.
    Coronary resting gradient measurements with cut-off values of ≤0.87 and ≥0.93 portend a high degree of certainty with respect to appropriateness of coronary revascularization Less agreement exists in patients in the so called indeterminate "gray zone" Pressure-bounded coronary flow reserve may aid in our understanding of the underlying physiologic principles and facilitate the clinical assessment of these lesions. Read More

    "To close or not to close?" When should vascular closure devices be used after cardiac catheterization procedures?
    Catheter Cardiovasc Interv 2017 Nov;90(5):766-767
    Department of Cardiology, Texas Heart Institute, Houston, Texas.
    Vascular closure devices (VCD) appear to be safe when compared to manual compression or surgical closure. VCDs' main advantage seems to stem from lower time to hemostasis (TTH) and time to mobilization. In anticoagulated patients with 6-Fr femoral sheaths, the new Celt ACT VCD, which uses a stainless-steel permanent implant, seems to be safe and decreases TTH when compared to manual pressure. Read More

    Differential responses to larger volume intra-aortic balloon counterpulsation: Hemodynamic and clinical outcomes.
    Catheter Cardiovasc Interv 2017 Oct 31. Epub 2017 Oct 31.
    Division of Cardiology, Newark Beth Israel Medical Center, Newark, New Jersey.
    Objectives: Examine hemodynamic and clinical correlates of use of an intra-aortic balloon pump catheter in a single center.

    Background: The intra-aortic balloon pump catheter (IABC) has been used for 50 years but the clinical benefit is still debated. We reviewed 76 patients with right heart catheter measurements prior to IABC to assess response and outcomes. Read More

    When high-volume PCI operators in high-volume hospitals move to lower volume hospitals-Do they still maintain high volume and quality of outcomes?
    Catheter Cardiovasc Interv 2017 Oct 31. Epub 2017 Oct 31.
    Division of Cardiology, Heart Center, Cheng Hsin General Hospital, and Faculty of Medicine, School of Medicine, National Yang Ming University, Taipei, Taiwan.
    Objectives: The aim of this quasi-experimental study was to examine whether high-volume percutaneous coronary intervention (PCI) operators still maintain high volume and quality of outcomes when they moved to lower volume hospitals.

    Background: Systematic reviews have indicated that high-volume PCI operators and hospitals have higher quality outcomes. However, little is known on whether high PCI volume and high quality outcomes are mainly due to operator characteristics (i. Read More

    Public unawareness of physician reimbursement.
    Catheter Cardiovasc Interv 2017 Oct 31. Epub 2017 Oct 31.
    Scripps Clinic, La Jolla, California.
    Objectives: To assess subjects' perception of healthcare costs and physician reimbursement.

    Background: The lack of transparency in healthcare reimbursement leaves patients and physicians unaware of the distribution of health care dollars.

    Methods: Anonymous survey-based study by means of convenience sampling. Read More

    Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.
    Catheter Cardiovasc Interv 2017 Oct 31. Epub 2017 Oct 31.
    Angiology Division, University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany.
    Objectives: The purpose of this study was to assess the safety and performance of Stellarex Drug-coated balloon (DCB).

    Background: DCB coatings differ in excipients, paclitaxel dose, and coating morphologies. Due to these differences, a class effect with DCBs has not been demonstrated. Read More

    One-year clinical and computed tomography follow-up after implantation of bioresorbable vascular scaffolds in patients with coronary chronic total occlusions.
    Catheter Cardiovasc Interv 2017 Oct 25. Epub 2017 Oct 25.
    Faculty of Medicine and Life Sciences, Universiteit Hasselt, Hasselt, Belgium.
    Objectives: To assess the safety and efficacy of everolimus-eluting bioresorbable scaffolds (BRS) in the treatment of chronic total occlusions (CTO) using noninvasive multislice computed tomography (MSCT) angiography at one-year follow-up.

    Background: Current evidence regarding the safety and efficacy of BRS for the percutaneous treatment of CTO is limited.

    Methods: Between September 2013 and January 2016, patients who received one or more ABSORB BRSs were included at three centers. Read More

    Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.
    Catheter Cardiovasc Interv 2017 Oct 25. Epub 2017 Oct 25.
    Division of Cardiology, University of North Carolina, Chapel Hill, North Carolina, 27599-7075.
    Background: In the recently concluded PARTNER 2 trial, TF-TAVR cohort was shown to have lower risks of death or disabling strokes as compared to SAVR, whereas the outcomes with transthoracic TAVR were comparable with SAVR.

    Methods: We searched PubMed, EMBASE, Web of Science, and Google Scholar for all comparison studies between TAVR and SAVR and mortality as an outcome, irrespective of surgical risk. Randomized controlled trials and propensity-score-matched cohort studies that used a transfemoral approach exclusively or stratified results by route of access and reported data for TF-TAVR patients were eligible for inclusion. Read More

    Predictors of in-hospital effectiveness and complications of rotational atherectomy (from the ORPKI Polish National Registry 2014-2016).
    Catheter Cardiovasc Interv 2017 Oct 25. Epub 2017 Oct 25.
    2nd Department of Cardiology and Cardiovascular Interventions, University Hospital, Krakow, Poland.
    Objective: The aim of the study was to assess trends in the use and periprocedural outcomes of rotational atherectomy (RA) in Poland between January 2014 and December 2016.

    Background: In recent years, due to the aging population, RA is becoming more commonly used to treat heavily calcified coronary artery stenoses.

    Methods: Data were prospectively collected using the Polish Cardiovascular Intervention Society national registry on all percutaneous coronary intervention (PCI) procedures performed in Poland. Read More

    Bioprosthetic tricuspid valve thrombosis: Percutaneous PFO closure to improve hypoxia and respiratory failure.
    Catheter Cardiovasc Interv 2017 Oct 25. Epub 2017 Oct 25.
    Department of Internal Medicine, Section on Cardiovascular Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
    Prosthetic valve thrombosis (PVT) is an increasingly recognized complication of bioprosthetic valve replacement, often resulting in abnormal hemodynamic, endothelial, and hemostatic conditions. Bioprosthetic PVT may lead to significant hemodynamic and clinical effects. In hemodynamically stable patients, first-line treatment for bioprosthetic PVT is systemic anticoagulation. Read More

    Interventional closure of patent foramen ovale with Nit-occlud® device in prevention of recurrent neurologic events-Long-term results.
    Catheter Cardiovasc Interv 2017 Oct 25. Epub 2017 Oct 25.
    Department of Cardiology, Poznan University of Medical Sciences, Poland.
    Background: Patent foramen ovale (PFO) was found to be associated with the increased risk of recurrent strokes or transient ischemic attacks (TIA) and there is a need of secondary prevention. Numerous devices have been developed and used for treatment.

    Objectives: The aim of the study was to evaluate the safety and effectiveness of a new PFO occluder Nit-Occlud PFO Occlusion Device (PFM medical, Germany). Read More

    Clinical and procedural outcomes with the SAPIEN 3 versus the SAPIEN XT prosthetic valves in transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv 2017 Oct 25. Epub 2017 Oct 25.
    Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.
    Objectives: The SAPIEN 3 valve (S3V) was designed to overcome the shortcomings of its predecessor, the SAPIEN XT (SXT) valve. We conducted a meta-analysis to compare their clinical outcomes and procedural characteristics.

    Methods: PUBMED, EMBASE, and Cochrane CENTRAL were searched by two independent reviewers. Read More

    A case of bronchopericardial fistula with tension pneumopericardium closed successfully by transpericardial intervention: A novel procedure.
    Catheter Cardiovasc Interv 2017 Oct 25. Epub 2017 Oct 25.
    Department of Medicine, Krishna Institute of Medical Sciences, Satara, Maharashtra, India.
    A pneumopericardium is a collection of air or gas in the pericardial sac which may cause cardiac tamponade, known as tension pneumopericardium. Tension pneumopericardium is a rare and lethal presentation of bronchopericardial fistula. There are very few reports in the literature of patients surviving with this condition, although prompt diagnosis and early intervention are important. Read More

    Comparison of transcatheter and surgical treatment of paravalvular leak: Results from a 5-year follow-up study.
    Catheter Cardiovasc Interv 2017 Oct 25. Epub 2017 Oct 25.
    Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, 241 West Huaihai Road, Shanghai, 200030, China.
    Objective: This study aimed to compare the efficacy and safety of two different treatments of paravalvular leak (PVL).

    Background: PVL is a common complication after surgical valve replacement. Re-operation is associated with high mortality, morbidity, and risk of re-leak. Read More

    Ostial right coronary chronic total occlusion: Transesophageal echocardiographic guidance for retrograde aortic re-entry.
    Catheter Cardiovasc Interv 2017 Oct 25. Epub 2017 Oct 25.
    Division of Cardiology, Emory University School of Medicine, Emory University Hospital, Atlanta, Georgia.
    As antegrade options are limited, intervention upon the ostial right coronary artery (RCA) chronic total occlusion (CTO) warrants a retrograde approach. Landmarks for an aggressive approach are concerning as passage of stiff guidewires or electrocautery near the RCA ostium may result in wire passage into structures other than the aorta. We report the first use of transesophageal echocardiography (TEE) to assist retrograde passage of a guidewire into the aorta. Read More

    Renal artery stenosis and ambulatory blood pressure monitoring: A case report and review of the literature.
    Catheter Cardiovasc Interv 2017 Oct 25. Epub 2017 Oct 25.
    Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, California.
    Renal artery stenosis (RAS) is a prevalent cause of secondary hypertension. Elderly patients with atherosclerosis and young women with fibromuscular dysplasia (FMD) are particularly at risk. Blood pressure screening is often key to this diagnosis, although the reliability of clinical screening has been questioned, and ambulatory blood pressure monitoring (ABPM) likely offers superior ability to diagnose poorly controlled hypertension. Read More

    1 OF 160